{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:46:24Z","timestamp":1791809184059,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04497-y","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:15:41Z","timestamp":1784189741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative mortality and survival after lymph node excision in hepatocellular carcinoma: a national cancer database propensity score\u2013matched cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Huisong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Uk","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"crossref","unstructured":"Meng F, Zhang H, Peng H, Lu S. Comparison of 10-year survival outcomes for early single hepatocellular carcinoma following different treatments. Biomed Res Int. 2021;2021:6638117.","DOI":"10.1155\/2021\/6638117"},{"key":"4497_CR2","first-page":"4470","volume":"25","author":"L Mocan","year":"2021","unstructured":"Mocan L. Multimodal therapy for hepatocellular carcinoma: the role of surgery. Eur Rev Med Pharmacol Sci. 2021;25:4470\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4497_CR3","first-page":"e9988","volume":"12","author":"T Walburn","year":"2020","unstructured":"Walburn T, Moon AM, Hayashi PH, Gerber D, Sanoff HK, McGinty KA, Mauro D, Tepper J, Wang K. Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation. Cureus. 2020;12:e9988.","journal-title":"Cureus"},{"key":"4497_CR4","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1245\/s10434-019-07843-5","volume":"27","author":"C Coon","year":"2020","unstructured":"Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Ann Surg Oncol. 2020;27:1156\u201363.","journal-title":"Ann Surg Oncol"},{"key":"4497_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.35772\/ghm.2019.01029","volume":"1","author":"Y Kawaguchi","year":"2019","unstructured":"Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CD, Vauthey JN. Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. Glob Health Med. 2019;1:55\u201360.","journal-title":"Glob Health Med"},{"key":"4497_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4174\/astr.2025.109.3.123","volume":"109","author":"MS Park","year":"2025","unstructured":"Park MS, Cho JY, Kim E, Na HY, Choi Y, Ki NR, Yoon YI, Lee B, Jang ES, Jung YK, Kim KS. Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association. Ann Surg Treat Res. 2025;109:123\u201343.","journal-title":"Ann Surg Treat Res"},{"key":"4497_CR7","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s11605-014-2667-1","volume":"18","author":"N Amini","year":"2014","unstructured":"Amini N, Ejaz A, Spolverato G, Maithel SK, Kim Y, Pawlik TM. Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review. J Gastrointest Surg. 2014;18:2136\u201348.","journal-title":"J Gastrointest Surg"},{"key":"4497_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00268-010-0400-0","volume":"34","author":"S Xiaohong","year":"2010","unstructured":"Xiaohong S, Huikai L, Feng W, Ti Z, Yunlong C, Qiang L. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg. 2010;34:1028\u201333.","journal-title":"World J Surg"},{"key":"4497_CR9","doi-asserted-by":"crossref","unstructured":"Voskanyan SE, Chuchuev ES, Rudakov VS, Vidmer EV. [Indications for lymph node dissection in hepatocellular carcinoma]. Khirurgiia (Mosk). 2022;6:5\u201310.","DOI":"10.17116\/hirurgia20220615"},{"key":"4497_CR10","doi-asserted-by":"publisher","first-page":"835957","DOI":"10.3389\/fonc.2022.835957","volume":"12","author":"X Chen","year":"2022","unstructured":"Chen X, Lu Y, Shi X, Han G, Zhao J, Gao Y, Wang X. Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma. Front Oncol. 2022;12:835957.","journal-title":"Front Oncol"},{"key":"4497_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/0003134821991983","volume":"88","author":"FS Dahdaleh","year":"2022","unstructured":"Dahdaleh FS, Naffouje SA, Sherman SK, Kamarajah SK, Salti GI. Tissue Diagnosis Is Associated With Worse Survival in Hepatocellular Carcinoma: A National Cancer Database Analysis. Am Surg. 2022;88:1234\u201343.","journal-title":"Am Surg"},{"key":"4497_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1015-9584(11)60020-1","volume":"34","author":"CW Lee","year":"2011","unstructured":"Lee CW, Chan KM, Lee CF, Yu MC, Lee WC, Wu TJ, Chen MF. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg. 2011;34:53\u201362.","journal-title":"Asian J Surg"},{"key":"4497_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12957-020-02099-w","volume":"18","author":"T Ishii","year":"2020","unstructured":"Ishii T, Ito T, Sumiyoshi S, Ogiso S, Fukumitsu K, Seo S, Taura K, Uemoto S. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. World J Surg Oncol. 2020;18:319.","journal-title":"World J Surg Oncol"},{"key":"4497_CR14","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.clinre.2023.102162","volume":"47","author":"MM Aloysius","year":"2023","unstructured":"Aloysius MM, Iskander P, Ahmed K, Asija U, Mohammed E, Iskander A, Shah NJ, Goyal H, Khurana V, Simin N, et al. Fibrolamellar hepatocellular carcinoma: An epidemiologic and 5-year cancer survival assessment based off SEER data. Clin Res Hepatol Gastroenterol. 2023;47:102162.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4497_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12957-025-03950-8","volume":"23","author":"H Lee","year":"2025","unstructured":"Lee H, Jung K, Luu M, Kosari K, Nissen N, Yang JD. Correlation between clinical and pathological nodal status in hepatocellular carcinoma: identifying risk factors for lymph node metastasis via the national cancer database. World J Surg Oncol. 2025;23:311.","journal-title":"World J Surg Oncol"},{"key":"4497_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/MCG.0000000000000277","volume":"49","author":"X Wu","year":"2015","unstructured":"Wu X, Li B, Qiu J, Shen J, Zheng Y, Li Q, Liao Y, He W, Zou R, Yuan Y. Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial. J Clin Gastroenterol. 2015;49:520\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"4497_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.surg.2022.07.026","volume":"173","author":"AD Mazzotta","year":"2023","unstructured":"Mazzotta AD, Kawaguchi Y, Pantel L, Tribillon E, Bonnet S, Gayet B, Soubrane O. Conditional cumulative incidence of postoperative complications stratified by complexity classification for laparoscopic liver resection: Optimization of in-hospital observation. Surgery. 2023;173:422\u20137.","journal-title":"Surgery"},{"key":"4497_CR18","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.ejso.2024.108010","volume":"50","author":"S Knitter","year":"2024","unstructured":"Knitter S, Raschzok N, Hillebrandt KH, Benzing C, Moosburner S, Nevermann N, Haber P, G\u00fcl-Klein S, Fehrenbach U, Lurje G, et al. Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry. Eur J Surg Oncol. 2024;50:108010.","journal-title":"Eur J Surg Oncol"},{"key":"4497_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10238-024-01296-1","volume":"24","author":"X Kang","year":"2024","unstructured":"Kang X, Liu X, Li Y, Yuan W, Xu Y, Yan H. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma. Clin Exp Med. 2024;24:44.","journal-title":"Clin Exp Med"},{"key":"4497_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.suronc.2020.12.011","volume":"36","author":"PM Kemp Bohan","year":"2021","unstructured":"Kemp Bohan PM, O\u2019Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, et al. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021;36:138\u201346.","journal-title":"Surg Oncol"},{"key":"4497_CR21","doi-asserted-by":"publisher","first-page":"e2435066","DOI":"10.1001\/jamanetworkopen.2024.35066","volume":"7","author":"M Yilma","year":"2024","unstructured":"Yilma M, Houhong Xu R, Saxena V, Muzzin M, Tucker LY, Lee J, Mehta N, Mukhtar N. Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System. JAMA Netw Open. 2024;7:e2435066.","journal-title":"JAMA Netw Open"},{"key":"4497_CR22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2147\/JHC.S420603","volume":"10","author":"S Tran","year":"2023","unstructured":"Tran S, Zou B, Kam L, Lee K, Huang DQ, Henry L, Cheung R, Nguyen MH. Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003\u20132021. J Hepatocell Carcinoma. 2023;10:2147\u201358.","journal-title":"J Hepatocell Carcinoma"},{"key":"4497_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jss.2022.03.006","volume":"276","author":"SP Schultz","year":"2022","unstructured":"Schultz SP, Holtestaul T, Marenco CW, Bader JO, Horton JD, Nelson DW. Prognostic Role of Lymph Node Sampling in Adolescent and Young Adults With Fibrolamellar Carcinoma. J Surg Res. 2022;276:261\u201371.","journal-title":"J Surg Res"},{"key":"4497_CR24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s11605-016-3216-x","volume":"20","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma. J Gastrointest Surg. 2016;20:1725\u201331.","journal-title":"J Gastrointest Surg"},{"key":"4497_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/liv.15826","volume":"44","author":"J Yang","year":"2024","unstructured":"Yang J, Choi J, Choi WM, Kim KM, Lee HC, Shim JH. Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC. Liver Int. 2024;44:907\u201319.","journal-title":"Liver Int"},{"key":"4497_CR26","first-page":"1414","volume":"49","author":"T Yoshida","year":"2022","unstructured":"Yoshida T, Tanaka M, Mohri K, Akiyama S, Yamagishi T, Murata K, Otsubo D, Furutani A, Yamane H, Sawa H, et al. [Long-Term Survival of a Patient with Hepatocellular Carcinoma after Surgical Resection of Metachronous Hilar Lymph Node Metastases]. Gan Kagaku Ryoho. 2022;49:1414\u20136.","journal-title":"Gan Kagaku Ryoho"},{"key":"4497_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.17998\/jlc.2021.09.10","volume":"21","author":"SY Hwang","year":"2021","unstructured":"Hwang SY, Lee SM, Lim JW, Jeon GJ, Lee HW. Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report. J Liver Cancer. 2021;21:177\u201380.","journal-title":"J Liver Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04497-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:03:09Z","timestamp":1791806589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04497-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04497-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8864371\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki, as revised in 2013. Because the National Cancer Database contains publicly available, deidentified data, this study was exempt from institutional review board review.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"392"}}